NCT00722553 2019-12-17Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary BladderAcrotech Biopharma Inc.Phase 2 Completed30 enrolled 12 charts
NCT00216099 2016-07-29Pemetrexed as Second-Line Therapy in Treating Patients With Hormone Refractory Prostate CancerHoosier Cancer Research NetworkPhase 2 Completed49 enrolled 15 charts